Rituximab and late-onset neutropenia: A French pharmacovigilance database analysis

被引:0
作者
Trouiller, C. [1 ]
Rouby, F. [1 ]
Jonville-Bera, A. P. [2 ]
Grandvuillemin, A. [3 ]
Bagheri, H. [4 ]
Micallef, J. [1 ]
机构
[1] CHU Timone, APHM, Serv Pharmacol Clin & Pharmacovigilance, Ctr Pharmacovigilance, Marseille, France
[2] CHRU, Ctr Reg Pharmacovigilance Tours, Tours, France
[3] CHU, Ctr Reg Pharmacovigilance Bourgogne, Serv Vigilances, Qual,Risques, Dijon, France
[4] Fac Med, Ctr Reg Pharmacovigilance, Serv Pharmacol Med & Clin, Toulouse, France
关键词
neutropenia; late-onset neutropenia; rituximab;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PS-017
引用
收藏
页码:95 / 96
页数:2
相关论文
共 2 条
  • [1] A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study
    Nitta, E.
    Izutsu, K.
    Sato, T.
    Ota, Y.
    Takeuchi, K.
    Kamijo, A.
    Takahashi, K.
    Oshima, K.
    Kanda, Y.
    Chiba, S.
    Motokura, T.
    Kurokawa, M.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (02) : 364 - 369
  • [2] Tchernonog E., 2014, CORRES ONCO HEMATOLO, V9, P164